Abstract
The use of intravenous (i.v.) antihypertensives in the treatment of cardiovascular-related hypertensive emergencies crosses distinct areas of clinical care and therapeutic applications. From first contact with emergency medical services (EMS) personnel, through the entire course of patient evaluation and care to medication considerations at the time of discharge, the applications for the i.v. antihypertensives are multiple and varied. This article describes the frequently encountered cardiovascular-related conditions found in their respective clinical settings and the utility of various antihypertensive treatment options.
Keywords: Hypertensive emergencies, intravenous antihypertensives, cardiovascular, acute coronary syndrome (ACS), perioperative hypertension, abdominal aortic aneurysm, catecholamine excess, deliberate hypotension
Current Vascular Pharmacology
Title: Intravenous Antihypertensives within Cardiovascular-Based Continuity of Care
Volume: 7 Issue: 2
Author(s): Joseph Varon and Albert T. Cheung
Affiliation:
Keywords: Hypertensive emergencies, intravenous antihypertensives, cardiovascular, acute coronary syndrome (ACS), perioperative hypertension, abdominal aortic aneurysm, catecholamine excess, deliberate hypotension
Abstract: The use of intravenous (i.v.) antihypertensives in the treatment of cardiovascular-related hypertensive emergencies crosses distinct areas of clinical care and therapeutic applications. From first contact with emergency medical services (EMS) personnel, through the entire course of patient evaluation and care to medication considerations at the time of discharge, the applications for the i.v. antihypertensives are multiple and varied. This article describes the frequently encountered cardiovascular-related conditions found in their respective clinical settings and the utility of various antihypertensive treatment options.
Export Options
About this article
Cite this article as:
Varon Joseph and Cheung T. Albert, Intravenous Antihypertensives within Cardiovascular-Based Continuity of Care, Current Vascular Pharmacology 2009; 7 (2) . https://dx.doi.org/10.2174/157016109787455590
DOI https://dx.doi.org/10.2174/157016109787455590 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fluocinolone Acetonide Implantable Device for Diabetic Retinopathy
Current Pharmaceutical Biotechnology Omentin: Linking Metabolic Syndrome and Cardiovascular Disease
Current Vascular Pharmacology Economic Evaluation in Paediatric Practice: Examples from Cardiac Critical Care
Current Pediatric Reviews Acute Actions of Natriuretic Peptides in Coronary Vasculature and Ischaemic Myocardium
Current Pharmaceutical Design The HCMV Chemokine Receptor US28 is a Potential Target in Vascular Disease
Current Drug Targets - Infectious Disorders Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design
Current Rheumatology Reviews Past, Present and Future of Nutrigenomics and its Influence on Drug Development
Current Drug Discovery Technologies Insulin Resistance as a Therapeutic Target for Improved Endothelial Function:Metformin
Current Drug Targets - Cardiovascular & Hematological Disorders Chromogranin A and the Endothelial Barrier Function
Current Medicinal Chemistry Novel Molecular Targets in the Treatment of Cardiac Hypertrophy
Recent Patents on Cardiovascular Drug Discovery Ebola Virus: Current and Future Perspectives
Infectious Disorders - Drug Targets Socioeconomic Position and Type 2 Diabetes Mellitus in Europe 1999- 2009: a Panorama of Inequalities
Current Diabetes Reviews Possible Involvement of Angiogenesis in Chronic Liver Diseases: Interaction Among Renin-Angiotensin-Aldosterone System, Insulin Resistance and Oxidative Stress
Current Medicinal Chemistry VIP in Neurological Diseases: More Than A Neuropeptide
Endocrine, Metabolic & Immune Disorders - Drug Targets Cortical and Putamen Age-Related Changes in the Microvessel Density and Astrocyte Deficiency in Spontaneously Hypertensive and Stroke-Prone Spontaneously Hypertensive Rats
Current Neurovascular Research Impact of Introducing Catheter-based Renal Denervation into Japan for Hypertension Management: Estimation of Number of Target Patients and Clinical Relevance of Ambulatory Blood Pressure Reduction
Current Hypertension Reviews Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases
Current Pharmaceutical Design Parathyroid Hypertension: A Rare, but Curable form of Secondary Hypertension
Current Hypertension Reviews Synthesis and Antithrombotic Activity Study of Some New Thienopyridine Derivatives
Letters in Organic Chemistry Clinical Implications of Recent Insights into the Structural Biology of Beta2 Adrenoceptors
Current Drug Targets